| Formulary Chapter 1: Gastro-intestinal system - Full Chapter
|
| 01.06.03 |
Faecal softeners |
|
|
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Medicines which should be prescribed by specialists only |
|
Drugs that have been reviewed and not recommended for prescribing. These drugs are not considered a cost-effective use of scarce NHS resources. There may be individual patient-specific or clinical reasons why a drug deemed low priority may be suitable for a particular patient. This is for the GP to consider, weighing up the reasons against his/her allocated CCG budget. Where the decision is made to prescribe a low priority drug, detailed documentation must be included in the patients' notes for audit purposes. *Please note that low priority drug requests are unsuitable for the Case Review Committee and therefore should not be sent to this committee.
Where new drugs come to market, under APC policy 085, they will be classified Brown until a review is deemed necessary. |
|
Medicines that should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the primary care provider that the prescribing responsibility has been transferred. Prescribing Guidelines are in place and must be adhered to. |
|
Medicines that should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the primary care provider that the prescribing responsibility has been transferred. Prescribing Guidelines are not required for these items. |
|
Medicines suitable for routine use and can be prescribed within primary care within their licensed indication in accordance with the BNF or other recognised national formulary. Primary care prescribers take full responsibility for prescribing |
|
Not Used
|
|
|
